SCHEDULE 13D: Stonehill Capital Management Discloses 19.6% Stake in Veradigm Inc., Signals Intent for Shareholder Engagement

Stonehill Capital Management and its affiliates have disclosed a 19.6% beneficial ownership stake in Veradigm Inc., totaling 21.14 million shares, acquired for $149.7 million, and indicate potential engagement with the company's board regarding governance and value maximization.

Summary

• Stonehill Capital Management LLC and its affiliated funds (Stonehill Master Fund Ltd. and Stonehill Institutional Partners, L.P.), along with several principals, have filed a Schedule 13D disclosing beneficial ownership of 21,141,983 shares of Veradigm Inc. Common Stock.
• This represents approximately 19.6% of Veradigm's outstanding Common Stock, calculated based on 107,639,978 shares outstanding as of April 9, 2024, and including the conversion of certain convertible notes.
• The shares were acquired for an aggregate purchase price of $149.7 million, funded by the working capital of Stonehill Master Fund Ltd. and Stonehill Institutional Partners, L.P.
• The Reporting Persons also hold $1.255 million in aggregate principal amount of Veradigm's 0.875% Convertible Senior Notes due 2027, convertible into 94,246 shares of Common Stock.
• The filing indicates that the Reporting Persons hold their shares for investment purposes and may engage in private communications with Veradigm's management and board regarding Board composition (at the Issuer's request) and other strategies to maximize stockholder value, including operations, management, capital structure, and corporate structure.
• Despite filing the 13D and potential engagement, the Reporting Persons will be deemed "Passive Investors" under Veradigm's amended Stockholder Rights Agreement.
• The Schedule 13D was filed out of an abundance of caution due to these communications, as they could potentially disqualify the Reporting Persons from reporting their ownership on a Schedule 13G.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. A large institutional investor taking a significant stake and signaling intent to engage with management for value creation is generally viewed favorably by the market, especially when the company itself has requested discussions on governance. However, the shift from 13G to 13D, even if for 'abundance of caution,' introduces a slight element of potential future activist pressure, which can be seen as a neutral to slightly negative factor depending on the outcome.

Positives

• A significant institutional investor, Stonehill Capital Management, has taken a substantial 19.6% stake, indicating confidence in Veradigm's long-term value.
• Stonehill's stated intent to engage with management and the board on topics like Board composition and value maximization could lead to positive strategic changes for the company.
• The Issuer itself requested discussions regarding Board composition, suggesting an openness to shareholder input.

Negatives

• The filing of a Schedule 13D, even if for "abundance of caution," signals a more active investor stance than a Schedule 13G, which could imply potential for future activist pressure or disagreements, though currently framed as collaborative.

Risks

• Potential for future disagreements between the Reporting Persons and Veradigm's management or Board regarding strategic direction, capital allocation, or corporate governance, despite the current "passive investor" designation.
• The need for the Issuer to amend its Stockholder Rights Agreement and request discussions on Board composition suggests existing governance considerations that may need addressing.

Future Outlook

The Reporting Persons hold their shares for investment purposes and intend to engage in private communications with Veradigm's management and board. These discussions may cover Board composition (at the Issuer's request) and other strategies to maximize stockholder value, including the Issuer's operations, management, capital structure, corporate structure, capital allocation, organizational documents, plans, and strategy.

Industry Context

This filing indicates a significant activist or engaged investor taking a large stake in a healthcare technology company. Such large stakes and stated intentions to engage with the board are common in industries undergoing strategic shifts, consolidation, or where investors perceive undervalued assets or operational inefficiencies. It suggests that Veradigm Inc. may be a target for shareholder-driven value creation initiatives.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased shareholder value if Stonehill's engagement leads to improved operations, capital allocation, or strategic initiatives. The large stake also signals a strong vote of confidence from a major investor.
• Management/Board: Increased scrutiny and potential pressure from a significant shareholder, requiring more active engagement and potentially leading to changes in strategy or governance.

Next Steps

• Private communications between the Reporting Persons and Veradigm's management and Board regarding Board composition and other strategies to maximize stockholder value.
• Potential review and reconsideration of position by Reporting Persons, and formulation of new plans or proposals.

Key Dates

Recommendation

Keywords

Veradigm Inc., Stonehill Capital Management, Schedule 13D, Beneficial Ownership, Shareholder Activism, Corporate Governance, Investment, Healthcare Technology, Convertible Notes, Stockholder Rights Agreement